Alzamend Neuro Stock Price History
ALZN Stock | USD 1.27 0.01 0.79% |
If you're considering investing in Alzamend Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alzamend Neuro stands at 1.27, as last reported on the 7th of January, with the highest price reaching 1.27 and the lowest price hitting 1.26 during the day. Alzamend Neuro secures Sharpe Ratio (or Efficiency) of -0.0827, which signifies that the company had a -0.0827% return per unit of risk over the last 3 months. Alzamend Neuro exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alzamend Neuro's Standard Deviation of 3.7, mean deviation of 2.7, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide.
As of the 7th of January 2025, Issuance Of Capital Stock is likely to grow to about 5.7 M, while Common Stock is likely to drop 75.38. . As of the 7th of January 2025, Price Earnings Ratio is likely to drop to -0.46. In addition to that, Price Book Value Ratio is likely to drop to -1.75. Alzamend Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Alzamend |
Sharpe Ratio = -0.0827
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ALZN |
Estimated Market Risk
3.73 actual daily | 33 67% of assets are more volatile |
Expected Return
-0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alzamend Neuro is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alzamend Neuro by adding Alzamend Neuro to a well-diversified portfolio.
Alzamend Neuro Stock Price History Chart
There are several ways to analyze Alzamend Stock price data. The simplest method is using a basic Alzamend candlestick price chart, which shows Alzamend Neuro price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 21, 2024 | 1.73 |
Lowest Price | December 20, 2024 | 1.11 |
Alzamend Neuro January 7, 2025 Stock Price Synopsis
Various analyses of Alzamend Neuro's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Alzamend Stock. It can be used to describe the percentage change in the price of Alzamend Neuro from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Alzamend Stock.Alzamend Neuro Price Daily Balance Of Power | 1.00 | |
Alzamend Neuro Price Action Indicator | 0.01 | |
Alzamend Neuro Price Rate Of Daily Change | 1.01 |
Alzamend Neuro January 7, 2025 Stock Price Analysis
Alzamend Stock Price History Data
The price series of Alzamend Neuro for the period between Wed, Oct 9, 2024 and Tue, Jan 7, 2025 has a statistical range of 0.62 with a coefficient of variation of 13.83. The prices are distributed with arithmetic mean of 1.42. The median price for the last 90 days is 1.45. The company had 1:10 stock split on 16th of July 2024.Open | High | Low | Close | Volume | ||
01/07/2025 | 1.26 | 1.27 | 1.26 | 1.27 | ||
01/06/2025 | 1.30 | 1.30 | 1.20 | 1.27 | 170,539 | |
01/03/2025 | 1.21 | 1.28 | 1.20 | 1.26 | 110,500 | |
01/02/2025 | 1.17 | 1.23 | 1.15 | 1.20 | 127,487 | |
12/31/2024 | 1.22 | 1.26 | 1.14 | 1.16 | 293,676 | |
12/30/2024 | 1.19 | 1.22 | 1.15 | 1.20 | 180,019 | |
12/27/2024 | 1.20 | 1.24 | 1.15 | 1.20 | 154,215 | |
12/26/2024 | 1.20 | 1.25 | 1.17 | 1.24 | 100,294 | |
12/24/2024 | 1.17 | 1.20 | 1.15 | 1.19 | 46,977 | |
12/23/2024 | 1.14 | 1.23 | 1.12 | 1.15 | 133,755 | |
12/20/2024 | 1.21 | 1.22 | 1.11 | 1.11 | 790,719 | |
12/19/2024 | 1.24 | 1.28 | 1.18 | 1.25 | 149,862 | |
12/18/2024 | 1.30 | 1.33 | 1.22 | 1.23 | 149,044 | |
12/17/2024 | 1.23 | 1.30 | 1.21 | 1.29 | 153,232 | |
12/16/2024 | 1.19 | 1.34 | 1.16 | 1.22 | 256,102 | |
12/13/2024 | 1.18 | 1.23 | 1.18 | 1.19 | 84,535 | |
12/12/2024 | 1.18 | 1.20 | 1.17 | 1.19 | 64,343 | |
12/11/2024 | 1.24 | 1.24 | 1.18 | 1.20 | 33,902 | |
12/10/2024 | 1.27 | 1.27 | 1.17 | 1.23 | 103,636 | |
12/09/2024 | 1.15 | 1.27 | 1.06 | 1.25 | 334,294 | |
12/06/2024 | 1.14 | 1.16 | 1.12 | 1.14 | 127,231 | |
12/05/2024 | 1.17 | 1.18 | 1.13 | 1.15 | 112,664 | |
12/04/2024 | 1.26 | 1.26 | 1.18 | 1.19 | 201,730 | |
12/03/2024 | 1.26 | 1.30 | 1.22 | 1.25 | 94,410 | |
12/02/2024 | 1.32 | 1.32 | 1.24 | 1.25 | 258,957 | |
11/29/2024 | 1.28 | 1.30 | 1.27 | 1.30 | 55,817 | |
11/27/2024 | 1.27 | 1.30 | 1.26 | 1.26 | 120,595 | |
11/26/2024 | 1.29 | 1.35 | 1.27 | 1.29 | 116,718 | |
11/25/2024 | 1.30 | 1.36 | 1.29 | 1.31 | 181,307 | |
11/22/2024 | 1.30 | 1.31 | 1.27 | 1.31 | 96,613 | |
11/21/2024 | 1.29 | 1.32 | 1.27 | 1.30 | 134,020 | |
11/20/2024 | 1.39 | 1.40 | 1.27 | 1.31 | 118,429 | |
11/19/2024 | 1.35 | 1.40 | 1.25 | 1.40 | 295,717 | |
11/18/2024 | 1.37 | 1.43 | 1.30 | 1.35 | 102,824 | |
11/15/2024 | 1.45 | 1.47 | 1.31 | 1.36 | 202,112 | |
11/14/2024 | 1.44 | 1.47 | 1.43 | 1.46 | 39,173 | |
11/13/2024 | 1.59 | 1.59 | 1.43 | 1.45 | 79,898 | |
11/12/2024 | 1.58 | 1.58 | 1.50 | 1.53 | 77,264 | |
11/11/2024 | 1.50 | 1.56 | 1.46 | 1.50 | 125,266 | |
11/08/2024 | 1.48 | 1.53 | 1.45 | 1.49 | 83,521 | |
11/07/2024 | 1.45 | 1.53 | 1.44 | 1.50 | 137,612 | |
11/06/2024 | 1.65 | 1.65 | 1.43 | 1.45 | 428,616 | |
11/05/2024 | 1.63 | 1.69 | 1.58 | 1.64 | 75,919 | |
11/04/2024 | 1.65 | 1.65 | 1.60 | 1.65 | 33,097 | |
11/01/2024 | 1.58 | 1.66 | 1.55 | 1.65 | 110,620 | |
10/31/2024 | 1.56 | 1.58 | 1.52 | 1.57 | 108,276 | |
10/30/2024 | 1.58 | 1.59 | 1.53 | 1.56 | 135,603 | |
10/29/2024 | 1.63 | 1.63 | 1.56 | 1.60 | 99,957 | |
10/28/2024 | 1.65 | 1.65 | 1.56 | 1.63 | 73,547 | |
10/25/2024 | 1.63 | 1.64 | 1.57 | 1.61 | 94,245 | |
10/24/2024 | 1.59 | 1.64 | 1.57 | 1.62 | 57,353 | |
10/23/2024 | 1.70 | 1.70 | 1.52 | 1.62 | 210,639 | |
10/22/2024 | 1.69 | 1.74 | 1.66 | 1.70 | 124,117 | |
10/21/2024 | 1.72 | 1.73 | 1.64 | 1.73 | 164,142 | |
10/18/2024 | 1.65 | 1.75 | 1.58 | 1.68 | 317,915 | |
10/17/2024 | 1.65 | 1.68 | 1.51 | 1.64 | 328,458 | |
10/16/2024 | 1.68 | 1.74 | 1.52 | 1.66 | 2,717,107 | |
10/15/2024 | 1.69 | 1.90 | 1.61 | 1.67 | 549,974 | |
10/14/2024 | 1.66 | 1.71 | 1.58 | 1.68 | 985,350 | |
10/11/2024 | 1.60 | 1.66 | 1.60 | 1.66 | 113,201 | |
10/10/2024 | 1.57 | 1.62 | 1.56 | 1.60 | 100,599 |
About Alzamend Neuro Stock history
Alzamend Neuro investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alzamend is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alzamend Neuro will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alzamend Neuro stock prices may prove useful in developing a viable investing in Alzamend Neuro
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 608.9 K | 578.5 K | |
Net Loss | -13.4 M | -12.7 M |
Alzamend Neuro Stock Technical Analysis
Alzamend Neuro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
Alzamend Neuro Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alzamend Neuro's price direction in advance. Along with the technical and fundamental analysis of Alzamend Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alzamend to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.39) | |||
Total Risk Alpha | (0.45) | |||
Treynor Ratio | 1.33 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.